ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2190

Multi-vendor Multi-site T1ρ and T2 Quantification of Knee Cartilage

Jeehun Kim 1, Kenji Mamoto 2, Richard Lartey 1, Kaipin Xu 1, Matthew Tanaka 3, Emma Bahroos 3, Carl Winalski 2, Thomas Link 3, Peter Hardy 4, Qi Peng 5, Angie Botto-van Bemden 6, Kecheng Liu 7, Robert Peters 8, Can Wu 9 and Xiaojuan Li10, 1Program of Advanced Musculoskeletal Imaging, Cleveland Clinic Foundation, Cleveland, 2Cleveland Clinic Foundation, Cleveland, 3University of California, San Francisco, San Francisco, 4University of Kentucky, Lexington, 5Albert Einstein College of Medicine, New York City, 6Arthritis Foundation, Atlanta, 7Siemens Medical Solution Inc, Malvern, 8GE Healthcare, Milwaukee, 9Philips Healthcare, Andover, 10Program of Advanced Musculoskeletal Imaging, Cleveland Clinic Foundation, Cleveland, OH

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: Magnetic resonance imaging (MRI), quantitative magnetic resonance imaging (qMRI), T1Rho quantitative imaging, T2 imaging and imaging standardization

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 12, 2019

Title: Osteoarthritis – Clinical Poster II

Session Type: Poster Session (Tuesday)

Session Time: 9:00AM-11:00AM

Background/Purpose: Osteoarthritis (OA) is a degenerative joint disease characterized by deterioration of articular cartilage in the joints. MRI T1ρ and T2 relaxation times have been proposed as potential biomarkers for early detection of cartilage degeneration. However, few studies examined their reliability in a multi-site multi-vendor setting, which is critical for future large-scale trials and clinical translation of such quantitative measures. The purpose of this study was to evaluate the intra-site repeatability and inter-site reproducibility of knee cartilage T1ρ and T2 data acquired by multiple sites and multiple vendors in phantoms and human subjects.

Methods: Four 3T MR systems from four different sites and three vendors (Siemens, GE, and Philips) with dedicated knee coils were used for this study (Table 1a). Five subjects were scanned with same day rescan at each site, including two traveling volunteers whose knees were scanned at all four sites. The imaging protocol included 3D T1ρ and T2 imaging, high-resolution gradient echo (GRE) imaging or dual echo steady state (DESS), and 3D turbo spin echo imaging (Table 1b). Data were transferred to one site for centralized data post-processing using in-house developed software. For all relaxation time fitting, two-parameter mono-exponential fittings were performed. The echo time or spin lock times used for fitting are listed in Table 1c. Cartilage was segmented semi-automatically into six compartments (medial/lateral femur [MFC/LFC], medial/lateral tibia [MT/LT, trochlea [TRO], and patellar [PAT]) using high-resolution DESS/GRE images, and the segmentation was overlaid on T1ρ and T2 maps after registration to calculate means and standard deviations of T1ρ and T2 values in each compartment.

Results: For phantoms, all sites showed excellent intra-site repeatability of T1ρ and T2 values with an average CV of 2.24% for T1ρ and of 2.53% for T2 (Table 2, Fig. 1). The average inter-site CVs were 7.67 % and 10.21 % for T1ρ and T2 respectively with both sequences included (four sites); and 7.64% and 6.62% for T1ρ and T2 respectively with the MAPSS sequence only (three sites).

For human subjects, excellent intra-site repeatability was observed for all sites with an average CV of 2.33% for T1ρ and of 2.91% for T2, Table 3. The average inter-site CVs were 13.50% and 28.15% for T1ρ and T2 respectively with both sequences included (four sites); and 8.2% and 10.17% for T1ρ and T2 respectively with MAPSS sequences only (three sites). Fig. 2 shows the T1ρ and T2 values of each defined cartilage compartment for the traveling volunteers.

Conclusion: Cartilage T1ρ and T2 imaging, after standardization of data acquisition and post-processing, demonstrates excellent intra-site repeatability, and inter-site reproducibility, suggesting great promise that T1ρ and T2 may serve as reliable imaging biomarkers for future multi-site and multi-vendor studies, after standardization of data acquisition and post-processing. Factors that could introduce variations in T1ρ and T2 values such as temperature, B0 and B1 inhomogeneity will be investigated further in future studies.


Table 1

Table 1. a- MRI system and coil setup. b- imaging parameters used for each sequences. c- TE -T2- and spin lock time -T1ρ- used in each site.


Table 2 FIG1

Table 2. Intra- and inter-site CV of a- T1ρ and b- T2 in phantoms. The MAPSS only inter-site CV was calculated using the mean values of site 1, 3 and 4.


Table 3 FIG2

Table 3. Intra- and inter-site CV of a- T1ρ and b- T2 in human subjects. The MAPSS only inter-site CV was calculated using the mean values of site 1, 3 and 4.


Disclosure: J. Kim, None; K. Mamoto, None; R. Lartey, None; K. Xu, None; M. Tanaka, None; E. Bahroos, None; C. Winalski, None; T. Link, None; P. Hardy, None; Q. Peng, None; A. Botto-van Bemden, None; K. Liu, Siemens Healthcare, 3; R. Peters, GE Healthcare, 3; C. Wu, Philips Healthcare, 3; X. Li, None.

To cite this abstract in AMA style:

Kim J, Mamoto K, Lartey R, Xu K, Tanaka M, Bahroos E, Winalski C, Link T, Hardy P, Peng Q, Botto-van Bemden A, Liu K, Peters R, Wu C, Li X. Multi-vendor Multi-site T1ρ and T2 Quantification of Knee Cartilage [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/multi-vendor-multi-site-t1%cf%81-and-t2-quantification-of-knee-cartilage/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/multi-vendor-multi-site-t1%cf%81-and-t2-quantification-of-knee-cartilage/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology